-
-
-
-
-
-
-
Scynexis (SCYX) is recalling BREXAFEMME from market and placing a temporary hold on clinical studies
-
-
-
-
-
-
-
Cara Therapeutics (CARA) Announces Approval of KORSUVA IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Announces Perioperative Regimen of Neoadjuvant Opdivo and Chemotherapy Followed by Adjuvant Opdivo Significantly Improves Event-Free Survival in Patients with Resectable Non
-
-
-
-
-
-
-
Zymeworks (ZYME) and BeiGene (BGNE) Terminate zanidatamab zovodotin Deal
-
-
-
-
-
-
-
Simulations Plus (SLP) Receives New FDA Grant Award
-
-
-
-
-
-
-
Travere Therapeutics (TVTX) Reports Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI Demonstrating Long-Term Kidney Function Preservation
-
-
-
-
-
-
-
Dyne Therapeutics (DYN) Granted FDA Orphan Drug Designation for DYNE-101
-
64,351 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.